Hjem › Ikke-muskulinvasiv blærecancer › Georgia
Kliniske studier for Ikke-muskulinvasiv blærecancer i Georgia
7 studier for Ikke-muskulinvasiv blærecancer søker deltakere på steder i Georgia.
Byer i Georgia
Offisiell studietekst (engelsk)
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Georgia Urology, Atlanta
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06919965A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital, Atlanta
- Emory University, Atlanta
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07206225Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
- Urology of Greater Atlanta - Sandy Springs, Atlanta
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 21. aug. 2026 · NCT07480356FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Emory University Hospital, Atlanta
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT05614739LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Emory University, Atlanta
- Georgia Cancer Center at Augusta University, Augusta
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 7. aug. 2026 · NCT04752722ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG
- Emory University, Atlanta
RekruttererFase 1/2
Alder 18 til 85 · Alle kjønn · Oppdatert 27. mar. 2026 · NCT06800963Blue Light Cystoscopy With Cysview® Registry
- Emory University School of Medicine, Atlanta
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 18. des. 2025 · NCT02660645Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.